BULLISH ON HISTO!Check this out... HSGX is looking primed to make a leg up. We're touching the 50-day ema on the weekly and we're beginning to cross the RSI of 55. Both great signs that HSGX is a strong buy. Check out the chart. Let me know what you think. Cheers and GL!
HSGX
Accumulation Trend $HSGXNice increase in accumulation and a bullish trend. I'm long on this one and patience is a virtue waiting on a news update about the status with the FDA concerning filing a BLA after their review of the PH3 results. Remember, the PH3 trial only failed by Histogenics standards and not by the FDA's standard. With approval from the FDA Histogenics will be the top dogs in the market for knee repair. GLTA
FDA Discussion Update on HistogenicsIn the HSGX longs community (i.e. Stocktwits) it is expected that there will be another update by the company CEO Adam Grizley by the end of year. As there haven't been any updates on the FDA discussions concerning BLA submission since 11-29-2018. The product NeoCart failed phase 3 because it didn't meet Histogenics criteria, not the FDA's. While the FDA continue to go over the data Histogenics stands by with a steady gain in SP.
Go long, go strong, or go home. I'm in for the ride through 2019. Maybe compounding in the dips along the way. Gonna be a great ride!
